JP2017526627A5 - - Google Patents

Download PDF

Info

Publication number
JP2017526627A5
JP2017526627A5 JP2016574989A JP2016574989A JP2017526627A5 JP 2017526627 A5 JP2017526627 A5 JP 2017526627A5 JP 2016574989 A JP2016574989 A JP 2016574989A JP 2016574989 A JP2016574989 A JP 2016574989A JP 2017526627 A5 JP2017526627 A5 JP 2017526627A5
Authority
JP
Japan
Prior art keywords
sequence number
polypeptide
seq
fragment
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016574989A
Other languages
English (en)
Japanese (ja)
Other versions
JP6818349B2 (ja
JP2017526627A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/037962 external-priority patent/WO2015200783A2/en
Publication of JP2017526627A publication Critical patent/JP2017526627A/ja
Publication of JP2017526627A5 publication Critical patent/JP2017526627A5/ja
Application granted granted Critical
Publication of JP6818349B2 publication Critical patent/JP6818349B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016574989A 2014-06-26 2015-06-26 アシネトバクター溶解素 Expired - Fee Related JP6818349B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462017618P 2014-06-26 2014-06-26
US62/017,618 2014-06-26
PCT/US2015/037962 WO2015200783A2 (en) 2014-06-26 2015-06-26 Acinetobacter lysins

Publications (3)

Publication Number Publication Date
JP2017526627A JP2017526627A (ja) 2017-09-14
JP2017526627A5 true JP2017526627A5 (enExample) 2018-08-09
JP6818349B2 JP6818349B2 (ja) 2021-01-20

Family

ID=54938953

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016574989A Expired - Fee Related JP6818349B2 (ja) 2014-06-26 2015-06-26 アシネトバクター溶解素

Country Status (14)

Country Link
US (2) US10590403B2 (enExample)
EP (1) EP3164146B1 (enExample)
JP (1) JP6818349B2 (enExample)
KR (1) KR102441211B1 (enExample)
CN (1) CN106659748B (enExample)
AU (1) AU2015279705B2 (enExample)
BR (1) BR112016030580B1 (enExample)
CA (1) CA2953446A1 (enExample)
ES (1) ES2767294T3 (enExample)
GB (1) GB2543453A (enExample)
IL (1) IL249636A0 (enExample)
NZ (1) NZ728429A (enExample)
RU (1) RU2725809C2 (enExample)
WO (1) WO2015200783A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10590403B2 (en) * 2014-06-26 2020-03-17 The Rockefeller University Acinetobacter lysins
JP2021506769A (ja) 2017-12-12 2021-02-22 コントラフェクト コーポレイション シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定
BR112020019484A2 (pt) 2018-03-29 2021-01-12 Contrafect Corporation Constructos polipeptídicos de lisina-peptídeo antimicrobiano (amp), lisinas, polinucleotídeos isolados codificando as mesmas e seus usos
US10988520B2 (en) 2018-03-29 2021-04-27 Contrafect Corporation Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
IL313959A (en) * 2018-08-23 2024-08-01 Contrafect Corp Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
JP2022526978A (ja) * 2019-04-05 2022-05-27 コントラフェクト コーポレイション ヒト血清の存在下でシュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体
CN111909917B (zh) * 2019-05-10 2022-10-14 中国科学院微生物研究所 一种内溶素Lysmeta1及其编码基因与应用
CN115605587B (zh) 2020-03-11 2026-02-13 特卢姆治疗有限公司 新型重组溶素及其在治疗革兰氏阴性菌感染中的用途
KR102604590B1 (ko) * 2020-09-28 2023-11-23 경북대학교 산학협력단 아시네토박터 바우마니에 대한 사멸능을 가지는 박테리오파지 및 이를 포함하는 조성물
KR102419028B1 (ko) * 2021-01-06 2022-07-08 주식회사 리신바이오 박테리오파지 유래 신규 재조합 엔도라이신 및 이의 용도
WO2022236088A1 (en) * 2021-05-06 2022-11-10 Bioharmony Therapeutics Inc. Lysin polypeptide compositions and methods of use
KR102776341B1 (ko) * 2023-11-24 2025-03-10 경북대학교 산학협력단 아시네토박터 바우마니에 대한 특이적 결합능을 갖는 재조합 단백질 및 이의 용도

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113298A1 (en) * 1997-10-31 2003-06-19 Vincent Fischetti Use of bacterial phage associated lysing proteins for the prophylactic and therapeutic treatment of various illnesses
US20060292135A1 (en) * 1997-10-31 2006-12-28 Lawrence Loomis Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US5997862A (en) * 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections
US6562958B1 (en) * 1998-06-09 2003-05-13 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
US6133010A (en) * 1999-07-08 2000-10-17 Biotec Asa Chlamysin B antibacterial protein, a protein gene for and an expression system for same
US20100233146A1 (en) * 2002-09-09 2010-09-16 Reactive Surfaces, Ltd. Coatings and Surface Treatments Having Active Enzymes and Peptides
US7604975B2 (en) * 2002-10-01 2009-10-20 The Rockefeller University Glycosylated LPXTGases and uses thereof
US7144712B2 (en) * 2003-07-30 2006-12-05 Vaccine Research Institute Of San Diego Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof
CA2534060C (en) * 2003-07-30 2012-06-12 Vaccine Research Institute Of San Diego Hepatitis virus core proteins as vaccine platforms and methods of use thereof
US7320795B2 (en) * 2003-07-30 2008-01-22 Vaccine Research Institute Of San Diego Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
US20070077235A1 (en) * 2004-01-16 2007-04-05 Lawrence Loomis Composition and method of treating mastitis
AU2007272272B2 (en) 2006-07-10 2012-04-12 Pba3 Biomed Gmbh Antimicrobial peptides
US9999635B2 (en) * 2007-01-16 2018-06-19 Realm Therapeutics, Inc. Methods and compositions for treating inflammatory disorders
US20110262508A1 (en) * 2007-11-07 2011-10-27 Paul Michael Watt Antimicrobial compositions, formulations and uses thereof
EP2157100A1 (en) 2008-08-19 2010-02-24 Profos AG Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins
GB0815484D0 (en) * 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
EP2349209A2 (en) * 2008-09-26 2011-08-03 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
WO2010061915A1 (ja) * 2008-11-28 2010-06-03 アンジェスＭｇ株式会社 血管新生誘導活性及び抗菌活性を有する新規ポリペプチド並びにその医薬用途
KR101016918B1 (ko) * 2009-01-08 2011-02-25 주식회사 인트론바이오테크놀로지 박테리아 특이적 넓은 항균 활성을 갖는 신규한 리신 단백질
DK2445515T3 (en) * 2009-06-26 2016-07-04 Univ Leuven Kath antimicrobial agents
MX2012002216A (es) 2009-08-24 2012-04-10 Univ Leuven Kath Nueva endolisina obpgplys.
US9005579B2 (en) * 2010-01-05 2015-04-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
US9534223B2 (en) * 2010-04-27 2017-01-03 Lysando Ag Method of reducing biofilms
EP3443970B1 (en) 2010-09-17 2020-09-09 Tecnifar-Indústria Técnica Farmacêutica, S.A. Antibacterial phage, phage peptides and methods of use thereof
EP2468856A1 (en) 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Antimicrobial Agents
GB201103780D0 (en) * 2011-03-04 2011-04-20 Hansa Medical Ab Treatment for ige-mediated disease
US9034322B2 (en) * 2011-04-21 2015-05-19 The Rockefeller University Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
WO2013052958A2 (en) * 2011-10-08 2013-04-11 Microbial Defense Systems, Llc Antimicrobial compositions and methods employing same
MX389127B (es) * 2012-05-09 2025-03-19 Contrafect Corp Lisina de bacteriófago y combinaciones de antibióticos contra bacterias gram positivas.
ES2729123T3 (es) * 2012-05-09 2019-10-30 Contrafect Corp Rotura de biopelícula con lisina plyss2
KR101391332B1 (ko) * 2012-05-18 2014-05-07 연세대학교 산학협력단 카바페넴 제제에 내성을 보이는 아시네토박터 속의 균을 용균하는 박테리오파아지
MX2015001817A (es) * 2012-08-08 2015-09-23 Avacyn Pharmaceuticals Inc Inhibicion de objetivos antimicrobianos con potencial reducido para la resistencia.
CN102940874B (zh) * 2012-12-12 2013-12-18 中国科学院昆明动物研究所 小分子多肽cw14在制备山羊抗菌药物中的应用
WO2014124047A1 (en) * 2013-02-06 2014-08-14 Academia Sinica Antimicrobial peptides derived from hepatitis b virus core protein arginine-rich domain
US10590403B2 (en) * 2014-06-26 2020-03-17 The Rockefeller University Acinetobacter lysins
AU2016313660B2 (en) * 2015-08-25 2019-11-07 Xiamen University Polypeptide carrier for presenting target polypeptide and uses thereof
EP3349780B1 (en) * 2015-09-17 2022-11-09 Contrafect Corporation Lysin polypeptides active against gram-negative bacteria
RU2754667C2 (ru) * 2016-05-12 2021-09-06 Контрафект Корпорейшн Способ микроразбавления в жидкой среде для оценки и определения минимальной ингибирующей концентрации антибактериальных полипептидов
CN117018170A (zh) * 2016-06-20 2023-11-10 Isa制药有限公司 肽疫苗制剂
BR112020019484A2 (pt) * 2018-03-29 2021-01-12 Contrafect Corporation Constructos polipeptídicos de lisina-peptídeo antimicrobiano (amp), lisinas, polinucleotídeos isolados codificando as mesmas e seus usos
US10988520B2 (en) * 2018-03-29 2021-04-27 Contrafect Corporation Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
WO2019226949A1 (en) * 2018-05-23 2019-11-28 The Rockefeller University Recombinant lysins
IL313959A (en) * 2018-08-23 2024-08-01 Contrafect Corp Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof

Similar Documents

Publication Publication Date Title
JP7267251B2 (ja) 抗菌組成物及び医薬組成物
Batoni et al. Therapeutic potential of antimicrobial peptides in polymicrobial biofilm-associated infections
Kosikowska et al. Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
Lebeaux et al. Management of infections related to totally implantable venous-access ports: challenges and perspectives
CN102906105B (zh) 肽及其用途
JP2013541333A5 (enExample)
RU2017102306A (ru) Лизины ацинетобактеров
RU2018146644A (ru) Композиции на основе каннабидиола и пути их применения
CN108348574A (zh) 具有对抗革兰氏阴性菌的活性的溶素多肽
ES2682670T3 (es) Lisinas de bacteriófagos de Streptococcus para la detección y tratamiento de bacterias gram positivas
JP2012517225A5 (enExample)
JP2014500714A5 (enExample)
JP2018512454A5 (enExample)
EP3852778A2 (en) Bioactive peptides derived from snakes
US20220048959A1 (en) Antimicrobial protein
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
JP2013539776A5 (enExample)
KR20180037185A (ko) 광범위의 항감염성 펩티드
JP2018531880A5 (enExample)
JP2014503469A5 (enExample)
JP2020117504A5 (enExample)
JP2015514093A5 (enExample)
HUE029860T2 (en) Antimicrobial peptides against infectious diseases
US12611380B2 (en) Solution and method for reducing the virulence of viruses, bacteria, yeasts, or fungus
JP2019523220A5 (enExample)